AU2002241726A1 - Compositions and therapeutical use of polynucleotides encoding tcrs - Google Patents

Compositions and therapeutical use of polynucleotides encoding tcrs

Info

Publication number
AU2002241726A1
AU2002241726A1 AU2002241726A AU4172602A AU2002241726A1 AU 2002241726 A1 AU2002241726 A1 AU 2002241726A1 AU 2002241726 A AU2002241726 A AU 2002241726A AU 4172602 A AU4172602 A AU 4172602A AU 2002241726 A1 AU2002241726 A1 AU 2002241726A1
Authority
AU
Australia
Prior art keywords
compositions
polynucleotides encoding
therapeutical use
encoding tcrs
tcrs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002241726A
Other languages
English (en)
Inventor
Juan Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of AU2002241726A1 publication Critical patent/AU2002241726A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
AU2002241726A 2000-11-02 2001-11-01 Compositions and therapeutical use of polynucleotides encoding tcrs Abandoned AU2002241726A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24548100P 2000-11-02 2000-11-02
US60/245,481 2000-11-02
PCT/US2001/050673 WO2002043774A2 (fr) 2000-11-02 2001-11-01 Immunisation d'acides nucleiques

Publications (1)

Publication Number Publication Date
AU2002241726A1 true AU2002241726A1 (en) 2002-06-11

Family

ID=22926841

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002241726A Abandoned AU2002241726A1 (en) 2000-11-02 2001-11-01 Compositions and therapeutical use of polynucleotides encoding tcrs

Country Status (4)

Country Link
EP (1) EP1392365A2 (fr)
JP (1) JP2004535358A (fr)
AU (1) AU2002241726A1 (fr)
WO (1) WO2002043774A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008043157A1 (fr) 2006-10-12 2008-04-17 The University Of Queensland Compositions et procédés destinés à moduler des réponses immunes
DK2635596T3 (da) 2010-11-01 2019-11-25 Univ Sydney Technology Immun-moduleringsmidler og anvendelser dertil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207645B1 (en) * 1989-03-21 2001-03-27 The Immune Response Corporation Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
CA2158733C (fr) * 1994-01-21 2007-01-16 Dennis E. Mccabe Instrument de depot de genes par entrainement gazeux
US5939400A (en) * 1996-02-26 1999-08-17 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for induction of suppressive T cell response
AU4479700A (en) * 1999-04-21 2000-11-02 Powderject Vaccines, Inc. Nucleic acid immunization

Also Published As

Publication number Publication date
WO2002043774A2 (fr) 2002-06-06
JP2004535358A (ja) 2004-11-25
EP1392365A2 (fr) 2004-03-03
WO2002043774A3 (fr) 2003-12-04

Similar Documents

Publication Publication Date Title
AU2001257326A1 (en) Topical anesthetic/opioid formulations and uses thereof
AU2002337953A1 (en) Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
EP1572880A3 (fr) Polynucleotides de defensine et methodes d'utilisation
HK1068555A1 (en) New formulations and use thereof
EP1227821A4 (fr) Compositions therapeutiques et leurs procedes d'utilisation
HUP0202864A3 (en) Endoparasiticidal gel composition preparation and use thereof
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2002251801A1 (en) Composition containing hedychium extract and use thereof
GB0119025D0 (en) Compounds and their therapeutic use
AU2002241726A1 (en) Compositions and therapeutical use of polynucleotides encoding tcrs
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU2002246858A1 (en) Human kinases and polynucleotides encoding the same
AU2002213183A1 (en) Human kinases and polynucleotides encoding the same
AU2001235003A1 (en) Novel human lysozymes and polynucleotides encoding the same
AU2001247214A1 (en) Hair treatment compositions and their use
AU3264202A (en) Novel human kinases and polynucleotides encoding the same
AU7057701A (en) New use as antihelmintics of albofungin and analogs
AU2001271917A1 (en) Genes encoding sinapoylglucose: malate sinapoyltransferase and methods of use
AU2001255708A1 (en) Synthesis and use of thienotriazolodiazepines
AU2002215923A1 (en) Use of medicaments
AU2001239815A1 (en) Hair treatment compositions and their use
HUP0204040A3 (en) Novel therapeutic use of enoxaparin
GB0112236D0 (en) Compounds and their therapeutic use